BFO
Boston Family Office Portfolio holdings
AUM
$1.51B
1-Year Return
12.61%
This Quarter Return
+8.66%
1 Year Return
+12.61%
3 Year Return
+54.38%
5 Year Return
+90.66%
10 Year Return
+237.26%
AUM
$1.05B
AUM Growth
+$87.6M
(+9.1%)
Cap. Flow
+$11.7M
Cap. Flow
% of AUM
1.11%
Top 10 Holdings %
Top 10 Hldgs %
25.51%
Holding
257
New
6
Increased
69
Reduced
106
Closed
4
Top Buys
| 1 |
Marsh & McLennan
MMC
|
+$17.5M |
| 2 |
AptarGroup
ATR
|
+$2.97M |
| 3 |
Chevron
CVX
|
+$992K |
| 4 |
Waste Management
WM
|
+$919K |
| 5 |
Microsoft
MSFT
|
+$727K |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$1.61M |
| 2 |
Apple
AAPL
|
+$1.15M |
| 3 |
Philip Morris
PM
|
+$989K |
| 4 |
CELG
Celgene Corp
CELG
|
+$924K |
| 5 |
Exxon Mobil
XOM
|
+$891K |
Sector Composition
| 1 | Technology | 18.67% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 10.29% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alphabet (Google) Class C
GOOG
$2.91T
| $12.2M | 1.16% |
182,680
+3,260
| +2% | +$218K |
|
27
Thermo Fisher Scientific
TMO
$186B
| $11.9M | 1.13% |
36,582
-227
| -0.6% | -$73.7K |
|
28
Stryker
SYK
$149B
| $11.8M | 1.12% |
56,250
+1,974
| +4% | +$414K |
|
29
NextEra Energy, Inc.
NEE
$147B
| $11.1M | 1.05% |
183,144
-3,060
| -2% | -$185K |
|
30
CVS Health
CVS
$94.7B
| $10.9M | 1.04% |
146,598
+5,615
| +4% | +$417K |
|
31
TE Connectivity
TEL
$62.8B
| $10.7M | 1.02% |
112,050
+2,316
| +2% | +$222K |
|
32
Roper Technologies
ROP
$55.7B
| $10.7M | 1.02% |
30,223
+74
| +0.2% | +$26.2K |
|
33
Verizon
VZ
$186B
| $10.6M | 1.01% |
173,286
+2,066
| +1% | +$127K |
|
34
General Mills
GIS
$27.1B
| $10.1M | 0.96% |
188,324
-946
| -0.5% | -$50.7K |
|
35
PepsiCo
PEP
$197B
| $10.1M | 0.96% |
73,668
+752
| +1% | +$103K |
|
36
Middleby
MIDD
$7.03B
| $9.21M | 0.88% |
84,103
+365
| +0.4% | +$40K |
|
37
Abbott
ABT
$231B
| $9.08M | 0.86% |
104,491
-314
| -0.3% | -$27.3K |
|
38
Dollar Tree
DLTR
$20.3B
| $8.91M | 0.85% |
94,738
+171
| +0.2% | +$16.1K |
|
39
Merck
MRK
$213B
| $8.79M | 0.84% |
101,262
-464
| -0.5% | -$40.3K |
|
40
Aflac
AFL
$58.1B
| $8.47M | 0.81% |
160,041
-695
| -0.4% | -$36.8K |
|
41
Invesco QQQ Trust
QQQ
$371B
| $8.37M | 0.8% |
39,370
-791
| -2% | -$168K |
|
42
Danaher
DHR
$140B
| $7.95M | 0.76% |
58,423
-1,517
| -3% | -$206K |
|
43
JPMorgan Chase
JPM
$840B
| $7.95M | 0.76% |
57,025
+3
| +0% | +$418 |
|
44
S&P Global
SPGI
$168B
| $7.7M | 0.73% |
28,206
| – | – |
|
45
McDonald's
MCD
$220B
| $7.36M | 0.7% |
37,264
| – | – |
|
|
46
Exxon Mobil
XOM
$478B
| $7.17M | 0.68% |
102,805
-12,767
| -11% | -$891K |
|
47
SS&C Technologies
SSNC
$22B
| $6.9M | 0.66% |
112,326
-3,825
| -3% | -$235K |
|
48
Idexx Laboratories
IDXX
$51.6B
| $6.75M | 0.64% |
25,855
-70
| -0.3% | -$18.3K |
|
49
Gilead Sciences
GILD
$146B
| $6.74M | 0.64% |
103,762
-2,048
| -2% | -$133K |
|
50
AbbVie
ABBV
$389B
| $6.51M | 0.62% |
73,572
+225
| +0.3% | +$19.9K |
|